PTGX · Protagonist Therapeutics, Inc · Share Buybacks
$127.16
+2.49 (+2.00%)
At close · Nov 18
Return incl. dividend (before tax)
Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18
433.18K
Avg daily vol (3M)
666.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1377121
CUSIP
74366E102
13F (30d)
382 filings
356 filers
Visit website
Investor relations